Today

Agents

Chat

Arena

Discover

More

App

BridgeBio CEO Neil Kumar disposes of common shares worth $691,023.06 - BBIO News | Rallies

BridgeBio CEO Neil Kumar disposes of common shares worth $691,023.06

BBIO•2026-09-21

CEO share sales and remaining holdings

BridgeBio Pharma CEO Neil Kumar sold 10,000 shares of common stock on Sept. 17, 2026.
Sales were priced at $69.01 to $69.57 per share.
Holdings via the Kumar Haldea Family Irrevocable Trust fell to 495,686 shares following the transactions.

Related News

IB Acquisition Corp Enters Equity Purchase Facility Agreement For Up To $50 Million In Class A Stock On Sept. 15

IBAC•2026-09-21

Ooma SVP, Chief Legal Officer Jenny Yeh sells 1,747 shares worth $40,181

OOMA•2026-09-21

Nebius Chief Revenue Officer Marc Boroditsky disposes of Class A shares worth $5,537,042

Sources

S

BridgeBio CEO Neil Kumar disposes of common shares worth $691,023.06

Sec

NBIS•2026-09-21

Tredegar files Form 3 for CFO Cindy Yao as initial beneficial ownership statement

TG•2026-09-21

Designer Brands director Harvey L. Sonnenberg sells 24,000 shares for $147,600

DBI•2026-09-21